Health Canada · Contribution program
National Strategy for Drugs for Rare Diseases Program
Canadian Health Systems and Programs
- Total value
- $2.8B
- Agreements
- 27
- Jul 2024 to Mar 2025
- Median agreement
- $39.6M
- Typical range
- $9.4M–$163M
- the middle half of agreements
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026.
See every record for this program on the government’s search. How to apply: look up the program on Health Canada’s website.
Who got it
Organizations with the most funding under this program.
By year
Agreements by the year they started.
Show the numbers
| Year | Agreements | Total |
|---|---|---|
| 2024 | 10 | $1.9B |
| 2025 | 17 | $942M |
By province
Per resident: the total over the whole window divided by the population on 1 July 2026 (Statistics Canada, table 17-10-0009-01). Agreements are placed by the recipient’s address, so a national organization’s funding counts where its office is.
| Province or territory | Agreements | Total |
|---|---|---|
| Ontario | 2 | $1.1B |
| Quebec | 2 | $611M |
| British Columbia | 2 | $388M |
| Alberta | 2 | $326M |
| Manitoba | 2 | $97.6M |
| Saskatchewan | 2 | $80.8M |
| Nova Scotia | 2 | $79.3M |
| New Brunswick | 2 | $64.7M |
| Newfoundland and Labrador | 2 | $44.6M |
| Northwest Territories | 3 | $20.7M |
| Prince Edward Island | 2 | $20.6M |
| Yukon | 2 | $17.1M |
| Nunavut | 2 | $14.8M |
By type of recipient
As the department classified the recipient.
| Recipient type | Agreements | Total |
|---|---|---|
| Government | 27 | $2.8B |